Treatment Efficacy for Drug Abuse and AIDS Prevention - 1

Phase 2

Completed

• Conditions: Heroin Dependence; Cocaine-Related Disorders

• Registration Number: NCT00000210
• Lead Sponsor: National Institute on Drug Abuse (NIDA)

Brief Summary

The purpose of this study is to assess the safety and effectiveness of buprenorphine for treatment of concurrent intravenous heroin and cocaine dependence.

Detailed Description

Not available

Study Timeline

• Study Start: 1989-09
• Primary Completion: 1996-02
• Study Completion: 1996-02
• Study First Submitted: 1999-09-20
• Study First Submitted QC: 1999-09-20
• Study First Posted: 1999-09-21
• Status Verified: 2002-12
• Last Update Submitted: 2017-01-11
• Last Update Posted: 2017-01-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

McLean Hospital, Dept. of Psychiatry; 🇺🇸 Belmont, Massachusetts, United States